Jennifer Foster MD MPH
Pediatric Hematologic Oncology, Pediatric Sarcoma Oncology, Pediatric Solid Tumor Oncology, Clinical Pharmacology
Associate Professor, Pediatrics, Baylor College of Medicine
Join to View Full Profile
6701 Fannin St.Suite 1400Houston, TX 77030
Phone+1 832-824-4646
Dr. Foster is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Baylor College of MedicineMS, 2013 - 2015
Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 2010 - 2013
University of WashingtonResidency, Pediatrics, 2007 - 2010
University of Hawaii, John A. Burns School of MedicineClass of 2007
Certifications & Licensure
TX State Medical License 2013 - 2026
HI State Medical License 2010 - 2016
WA State Medical License 2007 - 2010
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
American Board of Clinical PharmacologyClinical Pharmacology
Clinical Trials
- Individualized High Dose Methotrexate to Treat Cancer in Children Who Have a Significant Risk for Side Effects to Methotrexate Start of enrollment: 2014 Jan 01
- Pevonedistat, Irinotecan, and Temozolomide in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphoma Start of enrollment: 2018 Jan 11
- Study to Evaluate Safety and Dosimetry of Lutathera in Adolescent Patients With GEP-NETs and PPGLs Start of enrollment: 2022 Aug 31
Roles: Principal Investigator
Publications & Presentations
PubMed
- Real-World Experience Using Sodium Thiosulfate Pentahydrate Off-Label for Cisplatin Otoprotection in Children, Adolescents, and Young Adults.Julie Ma, Jennifer H Foster, Shahrad R Rassekh, Jemily Malvar, Yueh-Yun Chi
Pediatric Blood & Cancer. 2025-05-01 - Feasibility and Safety of Intratympanic Administration of Sustained-Exposure Dexamethasone Thermosensitive Gel (OTO-104) for Prevention of Cisplatin-Induced Hearing Lo...David R Freyer, Timothy J D Ohlsen, Debra Don, Etan Orgel, Robert J Hayashi
Pediatric Blood & Cancer. 2025-03-24 - Targeting the MYCN-MDM2 pathways for cancer therapy: Are they druggable?Wei Wang, Yi Du, Sayantap Datta, Josef F Fowler, Hannah T Sang
Genes & Diseases. 2025-03-01
Press Mentions
- Opioid Crisis Sparks Push to Return to 'Fundamentals of Pain Management'June 30th, 2021
Texas Girl Surprised with Super Bowl Tickets After Being Treated for Rare CancerFebruary 2nd, 2017
Texas Children's Cancer Center Alex's Lemonade Stand Center of ExcellenceSeptember 23rd, 2018
Committees
- Member, American Academy of Pediatrics Committee on Drugs 2017 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
